small molecule

MUCINEX

GUAIFENESIN

Loss of exclusivity—loss of exclusivity
CompanyRECKITT BENCKISER LLC

Drug detail

Brand nameMUCINEX
Active ingredientGUAIFENESIN
Strength600MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2002
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.